61 results on '"Horgan, Kieran"'
Search Results
2. Mastectomy patterns among older women with early invasive breast cancer in England and Wales: A population-based cohort study
3. Outcomes of complex oncoplastic breast surgery in older women. Analysis of data from the Age Gap cohort study
4. Completeness of endocrine therapy information in the Primary Care Prescription Database (PCPD) and secondary care treatment datasets: A national population-based cohort study using routine healthcare data
5. Concordance of cancer drug therapy information derived from routinely collected hospital admissions data and the Systemic Anti-Cancer Therapy (SACT) dataset, for older women diagnosed with early invasive breast cancer in England
6. HER2-enriched subtype and novel molecular subgroups drive aromatase inhibitor resistance and an increased risk of relapse in early ER+/HER2+ breast cancer
7. The MARECA (national study of management of breast cancer locoregional recurrence and oncological outcomes) study: National practice questionnaire of United Kingdom multi-disciplinary decision making
8. Observational cohort study to determine the degree and causes of variation in the rate of surgery or primary endocrine therapy in older women with operable breast cancer
9. The influence of age, comorbidity and frailty on treatment with surgery and systemic therapy in older women with operable triple negative breast cancer (TNBC) in England: A population-based cohort study
10. Long-term outcome and prognostic value of Ki67 after perioperative endocrine therapy in postmenopausal women with hormone-sensitive early breast cancer (POETIC): an open-label, multicentre, parallel-group, randomised, phase 3 trial
11. Costs of Early Invasive Breast Cancer in England Using National Patient-Level Data
12. Initiation of adjuvant chemotherapy and trastuzumab for human epidermal growth receptor 2-positive early invasive breast cancer in a population-based cohort study of older women in England
13. Addressing frailty in patients with breast cancer: A review of the literature
14. The B-MaP-C study: Breast cancer management pathways during the COVID-19 pandemic. Study protocol
15. Surgery and adjuvant radiotherapy for unilateral ductal carcinoma in situ (DCIS) in women aged over 70 years: A population based cohort study
16. Surgery induced immunosuppression
17. Intramammary lymph node metastasis predicts poorer survival in breast cancer patients
18. A randomised controlled trial of two programmes of shoulder exercise following axillary node dissection for invasive breast cancer
19. Breast symptomatic service: Referral numbers and cancer diagnoses by age and sex in England 2019/20
20. Agreement of breast cancer drug recording in routine hospital admissions & treatment data in England
21. Impact of the first two years of the COVID-19 pandemic on breast cancer diagnoses in England
22. Endocrine therapy in the years following a diagnosis of breast cancer: A proof of concept study using the primary care prescription database linked to cancer registration data
23. The MARECA (national study of management of breast cancer locoregional recurrence and oncological outcomes) study: National practice questionnaire of United Kingdom multi-disciplinary decision making
24. The association between guideline adherence, age and overall survival among women with non-metastatic breast cancer: A systematic review
25. Change in the use of fractionation in radiotherapy used for early breast cancer at the start of the COVID-19 pandemic: A population-based cohort study of older women in England and Wales
26. Does travel burden influence the use of radiotherapy after surgery for early invasive breast cancer in England?
27. Does the association between survival and receipt of post-mastectomy radiotherapy vary by age at diagnosis among women with early invasive breast cancer?
28. A prospective cohort study to analyse the effect of socioeconomic deprivation on breast cancer stage at diagnosis, treatment allocation and outcomes in older women in the United Kingdom.
29. Detection by fluorescence in situ hybridization of microdeletions at 1p36 in lymphomas, unidentified on cytogenetic analysis
30. 18. Post-mastectomy radiotherapy in older women with early invasive breast cancer -- data from the National Audit of Breast Cancer in Older Patients (NABCOP)
31. P115. Validation of endocrine therapy prescriptions with primary care prescriptions data for women newly-diagnosed with invasive breast cancer in England: Application to the NABCOP cohort
32. P106. Developing a patient guide to encourage questions and support decision-making around breast cancer treatment for older women - Experience of the national audit of breast cancer in older patients
33. P066: Patient and tumour factors affecting receipt of breast surgery in older women with ER-positive and ER-negative Early Invasive Breast Cancer (EIBC) in England and Wales: Data from the NABCOP
34. 09. SURGICAL RESECTION OF THE PRIMARY TUMOUR IN OLDER WOMEN WITH METASTATIC BREAST CANCER IN ENGLAND AND WALES
35. The Breast Angiosarcoma Surveillance Study
36. 28. The Breast Angiosarcoma Surveillance Study (BRASS)
37. 19. Surgery and systemic therapy in older women with early stage triple negative breast cancer (TNBC) in England: A population based cohort study within the National Audit of Breast Cancer in Older Patients (NABCOP)
38. 01. The effect of tumour risk and patient factors on the three-year survival for women with early stage triple negative breast cancer (TNBC) in England and Wales: A population based cohort study within National Audit of Breast Cancer in Older Patients (NABCOP)
39. 1974. Tumour-Infiltrating Lymphocytes Correlate with Circulating Lymphocytes and Influence Survival
40. 14. Tumour-infiltrating Lymphocytes Correlate with Circulating Lymphocytes and Influence Survival
41. Skin-sparing mastectomy: A novel method to maximise training opportunities
42. Post-mastectomy seromas and wound drains
43. 16. Is open diagnostic excision biopsy for B3 lesions redundant?
44. B3 pathologies and malignancy – Which are the risk lesions?
45. Loco-regional breast cancer recurrences: Some are diagnosed by clinical follow up
46. What happens to the axilla in patients with a complete pathological response following NACT at surgery: Experience from Leeds
47. Cytokeratin-19 based one-step nucleic acid amplification (OSNA) should not replace histopathology for sentinel lymph node assessment in breast cancer: A meta-analysis
48. Neoadjuvant endocrine therapy up-regulates expression of breast cancer resistance protein, but only pre-treatment levels predict survival
49. Role of ultrasound in the management of inguinal hernia in primary and secondary healthcare settings
50. Pathological evaluation of the staging axillary lymph nodes: A national survey in the United Kingdom
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.